{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:02:35Z","timestamp":1776265355968,"version":"3.50.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13365-025-01299-y","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:30:52Z","timestamp":1770906652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arboviruses in Cancer therapy: pros and cons"],"prefix":"10.1007","volume":"32","author":[{"given":"Fereshteh","family":"Asgharzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanieh","family":"Yaghoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atieh","family":"Yaghoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"3","key":"1299_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ijc.33249","volume":"148","author":"P Altevogt","year":"2021","unstructured":"Altevogt P, Sammar M, H\u00fcser L, Kristiansen G (2021) Novel insights into the function of CD24: a driving force in cancer. Int J Cancer 148(3):546\u2013559","journal-title":"Int J Cancer"},{"key":"1299_CR2","doi-asserted-by":"crossref","unstructured":"Anraku I, Harvey TJ, Linedale R, Gardner J, Harrich D, Suhrbier A et al (2002) Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. 76(8):3791\u20133799","DOI":"10.1128\/JVI.76.8.3791-3799.2002"},{"issue":"9","key":"1299_CR3","doi-asserted-by":"publisher","first-page":"e12670","DOI":"10.1371\/journal.pone.0012670","volume":"5","author":"F Avogadri","year":"2010","unstructured":"Avogadri F, Merghoub T, Maughan MF, Hirschhorn-Cymerman D, Morris J, Ritter E et al (2010) Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity. PLoS One 5(9):e12670","journal-title":"PLoS One"},{"issue":"5","key":"1299_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1158\/2326-6066.CIR-13-0220","volume":"2","author":"F Avogadri","year":"2014","unstructured":"Avogadri F, Zappasodi R, Yang A, Budhu S, Malandro N, Hirschhorn-Cymerman D et al (2014) Combination of alphavirus replicon particle\u2013based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates. Cancer Immunol Res 2(5):448\u2013458","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"1299_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1586\/erv.10.55","volume":"9","author":"D Bedognetti","year":"2010","unstructured":"Bedognetti D, Wang E, Sertoli MR, Marincola FM (2010) Gene-expression profiling in vaccine therapy and immunotherapy for cancer. Expert Rev Vaccines 9(6):555\u2013565","journal-title":"Expert Rev Vaccines"},{"key":"1299_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cois.2014.07.005","volume":"3","author":"CD Blair","year":"2014","unstructured":"Blair CD, Olson KE (2014) Mosquito immune responses to arbovirus infections. Curr Opin Insect Sci 3:22\u201329","journal-title":"Curr Opin Insect Sci"},{"issue":"10213","key":"1299_CR7","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(19)32790-4","volume":"394","author":"OJ Brady","year":"2019","unstructured":"Brady OJ, Hay SI (2019) The first local cases of Zika virus in Europe. Lancet 394(10213):1991\u20131992","journal-title":"Lancet"},{"key":"1299_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ebiom.2016.06.046","volume":"9","author":"C Breitbach","year":"2016","unstructured":"Breitbach C, Lichty B, Bell J (2016) Oncolytic viruses: therapeutics with an identity crisis. EBioMedicine 9:31\u201336","journal-title":"EBioMedicine"},{"key":"1299_CR9","doi-asserted-by":"crossref","unstructured":"Bulatov E, Sayarova R, Mingaleeva R, Miftakhova R, Gomzikova M, Ignatyev Y, et al. Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors 2018;4(1):103","DOI":"10.1038\/s41420-018-0120-z"},{"key":"1299_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.omto.2022.01.011","volume":"24","author":"L Chen","year":"2022","unstructured":"Chen L, Zhou C, Chen Q, Shang J, Liu Z, Guo Y et al (2022) Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma. Mol Ther Oncolytics 24:522\u2013534","journal-title":"Mol Ther Oncolytics"},{"key":"1299_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01683-18","volume":"9","author":"Q Chen","year":"2018","unstructured":"Chen Q, Shi P (2018) Treatment of human glioblastoma with a live attenuated Zika virus vaccine candidate. mBio 9:e01683\u2013e01618","journal-title":"mBio"},{"issue":"10","key":"1299_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen Q, Sun L, Chen ZJ (2016) Regulation and function of the cGAS\u2013STING pathway of cytosolic DNA sensing. Nat Immunol 17(10):1142\u20131149","journal-title":"Nat Immunol"},{"key":"1299_CR13","doi-asserted-by":"crossref","unstructured":"Cohn D, Nuovo G, Coffey M, O'Malley D, Villalona-Calero M, Grever M et al (2010) Phase I\/II trial of reovirus serotype 3\u2013Dearing strain in patients with recurrent ovarian cancer. 28(15_suppl):TPS253","DOI":"10.1200\/jco.2010.28.15_suppl.tps253"},{"issue":"3","key":"1299_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0566-9","volume":"19","author":"ND Collins","year":"2017","unstructured":"Collins ND, Barrett ADT (2017) Live attenuated yellow fever 17D vaccine: a legacy vaccine still controlling outbreaks in modern day. Curr Infect Dis Rep 19(3):14","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","volume":"118","author":"DV Correia","year":"2011","unstructured":"Correia DV, Fogli M, Hudspeth K, Da Silva MG, Mavilio D, Silva-Santos BJB (2011) Differentiation of human peripheral blood V\u03b41+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 118(4):992\u20131001","journal-title":"Blood"},{"issue":"9","key":"1299_CR16","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-18-3102","volume":"25","author":"EJ Crosby","year":"2019","unstructured":"Crosby EJ, Gwin W, Blackwell K, Marcom PK, Chang S, Maecker HT et al (2019) Vaccine-induced memory CD8+ T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study. Clin Cancer Res 25(9):2725\u20132736","journal-title":"Clin Cancer Res"},{"issue":"41","key":"1299_CR17","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","volume":"27","author":"PC da Costa Neves","year":"2009","unstructured":"da Costa Neves PC, de Souza Matos DC, Marcovistz R, Galler R (2009) TLR expression and NK cell activation after human yellow fever vaccination. Vaccine 27(41):5543\u20135549","journal-title":"Vaccine"},{"issue":"11\u201312","key":"1299_CR18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0264-410X(02)00558-3","volume":"21","author":"T Daemen","year":"2003","unstructured":"Daemen T, Riezebos-Brilman A, Bungener L, Regts J, Dontje B, Wilschut J (2003) Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7. Vaccine 21(11\u201312):1082\u20131088","journal-title":"Vaccine"},{"issue":"10","key":"1299_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41417-022-00463-4","volume":"29","author":"AM Davis","year":"2022","unstructured":"Davis AM, Scott TA, Morris KV (2022) Harnessing Rift Valley fever virus NSs gene for cancer gene therapy. Cancer Gene Ther 29(10):1477\u20131486","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"1299_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.it.2012.05.008","volume":"33","author":"MS Diamond","year":"2012","unstructured":"Diamond MS, Gale M (2012) Cell-intrinsic innate immune control of West Nile virus infection. Trends Immunol 33(10):522\u2013530","journal-title":"Trends Immunol"},{"issue":"3","key":"1299_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","volume":"162","author":"MS Diamond","year":"2015","unstructured":"Diamond MS, Pierson TC (2015) Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell 162(3):488\u2013492","journal-title":"Cell"},{"issue":"12","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1002\/eji.201243150","volume":"43","author":"P Dokouhaki","year":"2013","unstructured":"Dokouhaki P, Schuh NW, Joe B, Allen CA, Der SD, Tsao MS et al (2013) NKG 2 D regulates production of soluble TRAIL by ex vivo expanded human \u03b3\u03b4 T cells. Eur J Immunol 43(12):3175\u20133182","journal-title":"Eur J Immunol"},{"issue":"13","key":"1299_CR23","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-06-2202","volume":"13","author":"RJ Durso","year":"2007","unstructured":"Durso RJ, Andjelic S, Gardner JP, Margitich DJ, Donovan GP, Arrigale RR et al (2007) A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses. Clin Cancer Res 13(13):3999\u20134008","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1299_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13050939","volume":"13","author":"M Ehrlich","year":"2021","unstructured":"Ehrlich M, Bacharach E (2021) Oncolytic virotherapy: the cancer cell side. Cancers 13(5):939","journal-title":"Cancers"},{"issue":"7","key":"1299_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMp1600297","volume":"374","author":"AS Fauci","year":"2016","unstructured":"Fauci AS, Morens DM (2016) Zika virus in the Americas\u2014yet another arbovirus threat. N Engl J Med 374(7):601\u2013604","journal-title":"N Engl J Med"},{"issue":"1","key":"1299_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11866-7","volume":"10","author":"CP Figueiredo","year":"2019","unstructured":"Figueiredo CP, Barros-Arag\u00e3o FG, Neris RL, Frost PS, Soares C, Souza IN et al (2019) Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nat Commun 10(1):3890","journal-title":"Nat Commun"},{"key":"1299_CR27","doi-asserted-by":"crossref","unstructured":"Flinsenberg TW, Compeer EB, Koning D, Klein M, Amelung FJ, van Baarle D et al (2012) Fc\u03b3 receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells. 120(26):5163\u20135172","DOI":"10.1182\/blood-2012-06-434498"},{"issue":"3","key":"1299_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.mt.6300403","volume":"16","author":"P Forsyth","year":"2008","unstructured":"Forsyth P, Rold\u00e1n G, George D, Wallace C, Palmer CA, Morris D et al (2008) A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas. Mol Ther 16(3):627\u2013632","journal-title":"Mol Ther"},{"issue":"2","key":"1299_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G (2017) Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 17(2):97\u2013111","journal-title":"Nat Rev Immunol"},{"key":"1299_CR30","doi-asserted-by":"crossref","unstructured":"Gandini M, Gras C, Azeredo EL, Pinto LMO, Smith N, Despres P et al (2013) Dengue virus activates membrane TRAIL relocalization and IFN-\u03b1 production by human plasmacytoid dendritic cells in vitro and in vivo. 7(6):e2257","DOI":"10.1371\/journal.pntd.0002257"},{"key":"1299_CR31","doi-asserted-by":"crossref","unstructured":"Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R et al (2016a) Zika virus impairs growth in human neurospheres and brain organoids. 352(6287):816\u2013818","DOI":"10.1126\/science.aaf6116"},{"issue":"6287","key":"1299_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.aaf6116","volume":"352","author":"PP Garcez","year":"2016","unstructured":"Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R et al (2016b) Zika virus impairs growth in human neurospheres and brain organoids. Science 352(6287):816\u2013818","journal-title":"Science"},{"key":"1299_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.virusres.2017.08.015","volume":"254","author":"GP G\u00f6ertz","year":"2018","unstructured":"G\u00f6ertz GP, Abbo SR, Fros JJ, Pijlman GP (2018) Functional RNA during Zika virus infection. Virus Res 254:41\u201353","journal-title":"Virus Res"},{"key":"1299_CR34","doi-asserted-by":"crossref","unstructured":"Goldufsky JW, Chen T, Singh G, Zloza A, Marzo AL, Lyday BJTJoI. Dengue virus induces human immune cells to secrete factors capable of tumor cell killing and activation of effector cells against treatment-resistant tumors 2021;206(1_Supplement):67.16-67.16","DOI":"10.4049\/jimmunol.206.Supp.67.16"},{"key":"1299_CR35","doi-asserted-by":"crossref","unstructured":"Gollamudi R, Ghalib MH, Desai KK, Chaudhary I, Wong B, Einstein M et al (2010) Intravenous administration of Reolysin\u00ae, a live replication competent RNA virus is safe in patients with advanced solid tumors. 28(5):641\u2013649","DOI":"10.1007\/s10637-009-9279-8"},{"issue":"8","key":"1299_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/cgt.2012.33","volume":"19","author":"T Granot","year":"2012","unstructured":"Granot T, Meruelo D (2012) The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan. Cancer Gene Ther 19(8):588\u2013591","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"1299_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/mt.2013.215","volume":"22","author":"T Granot","year":"2014","unstructured":"Granot T, Yamanashi Y, Meruelo D (2014) Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity. Mol Ther 22(1):112\u2013122","journal-title":"Mol Ther"},{"key":"1299_CR38","first-page":"e1442169","volume-title":"Heating it up: oncolytic viruses make tumors \u2018hot\u2019and suitable for checkpoint blockade immunotherapies","author":"S Gujar","year":"2018","unstructured":"Gujar S, Pol JG, Kroemer G (2018) Heating it up: oncolytic viruses make tumors \u2018hot\u2019and suitable for checkpoint blockade immunotherapies. Taylor & Francis, p e1442169"},{"key":"1299_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(03)60011-4","volume-title":"Neutralization and antibody-dependent enhancement of dengue viruses","author":"SB Halstead","year":"2003","unstructured":"Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. 2003"},{"key":"1299_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.968582","volume":"13","author":"M Hameed","year":"2022","unstructured":"Hameed M, Geerling E, Pinto AK, Miraj I, Weger-Lucarelli J (2022) Immune response to arbovirus infection in obesity. Front Immunol 13:968582","journal-title":"Front Immunol"},{"key":"1299_CR41","doi-asserted-by":"crossref","unstructured":"Harrington KJ, Karapanagiotou EM, Roulstone V, Twigger KR, White CL, Vidal L et al (2010) Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. 16(11):3067\u20133077","DOI":"10.1158\/1078-0432.CCR-10-0054"},{"issue":"2","key":"1299_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.virol.2003.10.032","volume":"319","author":"KA Herd","year":"2004","unstructured":"Herd KA, Harvey T, Khromykh AA, Tindle RW (2004) Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour. Virology 319(2):237\u2013248","journal-title":"Virology"},{"key":"1299_CR43","doi-asserted-by":"crossref","unstructured":"Hoang-Le D, Smeenk L, Anraku I, Pijlman G, Wang X, De Vrij J et al (2009) A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy. 16(2):190\u2013199","DOI":"10.1038\/gt.2008.169"},{"issue":"1","key":"1299_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41597-023-02226-8","volume":"10","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang S, Liu H, Atoni E, Wang F, Chen W et al (2023) A global dataset of sequence, diversity and biosafety recommendation of arbovirus and arthropod-specific virus. Sci Data 10(1):305","journal-title":"Sci Data"},{"issue":"7","key":"1299_CR45","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/gt.2015.24","volume":"22","author":"P Ip","year":"2015","unstructured":"Ip P, Boerma A, Walczak M, Oosterhuis K, Haanen J, Schumacher T et al (2015) Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines. Gene Ther 22(7):560\u2013567","journal-title":"Gene Ther"},{"key":"1299_CR46","doi-asserted-by":"crossref","unstructured":"Kaid C, dos Santos Madi RA, Astray R, Goulart E, Caires-Junior LC, Mitsugi TG et al (2020) Safety, tumor reduction, and clinical impact of Zika virus injection in dogs with advanced-stage brain tumors. 28(5):1276\u20131286","DOI":"10.1016\/j.ymthe.2020.03.004"},{"issue":"12","key":"1299_CR47","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1158\/0008-5472.CAN-17-3201","volume":"78","author":"C Kaid","year":"2018","unstructured":"Kaid C, Goulart E, Caires-J\u00fanior LC, Araujo BH, Soares-Schanoski A, Bueno HM et al (2018a) Zika virus selectively kills aggressive human embryonal CNS tumor cells in vitro and in vivo. Cancer Res 78(12):3363\u20133374","journal-title":"Cancer Res"},{"key":"1299_CR48","doi-asserted-by":"crossref","unstructured":"Kaid C, Goulart E, Caires-J\u00fanior LC, Araujo BH, Soares-Schanoski A, Bueno HM et al (2018b) Zika virus selectively kills aggressive human embryonal CNS tumor cells in vitro and in vivo. 78(12):3363\u20133374","DOI":"10.1158\/0008-5472.CAN-17-3201"},{"issue":"7","key":"1299_CR49","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-11-2181","volume":"18","author":"EM Karapanagiotou","year":"2012","unstructured":"Karapanagiotou EM, Roulstone V, Twigger K, Ball M, Tanay M, Nutting C et al (2012) Phase I\/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin Cancer Res 18(7):2080\u20132089","journal-title":"Clin Cancer Res"},{"key":"1299_CR50","doi-asserted-by":"crossref","unstructured":"Kicielinski KP, Chiocca EA, John SY, Gill GM, Coffey M, Markert JMJMT (2014) Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults. 22(5):1056\u20131062","DOI":"10.1038\/mt.2014.21"},{"issue":"2","key":"1299_CR51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","volume":"29","author":"FL Komdeur","year":"2021","unstructured":"Komdeur FL, Singh A, van de Wall S, Meulenberg JJ, Boerma A, Hoogeboom BN et al (2021) First-in-human phase I clinical trial of an SFV-based RNA replicon cancer vaccine against HPV-induced cancers. Mol Ther 29(2):611\u2013625","journal-title":"Mol Ther"},{"issue":"23","key":"1299_CR52","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.1128\/JVI.00841-11","volume":"85","author":"J Kortekaas","year":"2011","unstructured":"Kortekaas J, Oreshkova N, Cobos-Jim\u00e9nez V, Vloet RP, Potgieter CA, Moormann RJM (2011) Creation of a nonspreading Rift Valley fever virus. J Virol 85(23):12622\u201312630","journal-title":"J Virol"},{"issue":"1","key":"1299_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1618-x","volume":"15","author":"MG Kramer","year":"2015","unstructured":"Kramer MG, Masner M, Casales E, Moreno M, Smerdou C, Chabalgoity JA (2015) Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice. BMC Cancer 15(1):620","journal-title":"BMC Cancer"},{"issue":"28","key":"1299_CR54","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.18632\/oncotarget.4584","volume":"6","author":"L Lezina","year":"2015","unstructured":"Lezina L, Aksenova V, Fedorova O, Malikova D, Shuvalov O, Antonov AV et al (2015) KMT set7\/9 affects genotoxic stress response via the Mdm2 axis. Oncotarget 6(28):25843","journal-title":"Oncotarget"},{"key":"1299_CR55","doi-asserted-by":"crossref","unstructured":"Li H, Hu Y, Huang J, Feng Y, Zhang Z, Zhong K et al (2019) Zika virus NS5 protein inhibits cell growth and invasion of glioma. 516(2):515\u2013520","DOI":"10.1016\/j.bbrc.2019.06.064"},{"issue":"12","key":"1299_CR56","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nbt1291-1356","volume":"9","author":"P Liljestr\u00f6m","year":"1991","unstructured":"Liljestr\u00f6m P, Garoff H (1991) A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio\/technology 9(12):1356\u20131361","journal-title":"Bio\/technology"},{"issue":"1","key":"1299_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01407-6","volume":"8","author":"D Lin","year":"2023","unstructured":"Lin D, Shen Y, Liang T (2023) Oncolytic virotherapy: basic principles, recent advances and future directions. Signal Transduct Target Ther 8(1):156","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1299_CR58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.7150\/thno.65773","volume":"12","author":"K Liu","year":"2022","unstructured":"Liu K, Hoover AR, Krawic JR, DeVette CI, Sun X-H, Hildebrand WH et al (2022) Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival. Theranostics 12(2):639","journal-title":"Theranostics"},{"key":"1299_CR59","doi-asserted-by":"crossref","unstructured":"Lolkema MP, Arkenau H-T, Harrington K, Roxburgh P, Morrison R, Roulstone V et al (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. 17(3):581\u2013588","DOI":"10.1158\/1078-0432.CCR-10-2159"},{"issue":"5","key":"1299_CR60","doi-asserted-by":"publisher","first-page":"E113","DOI":"10.1093\/neuros\/nyy047","volume":"82","author":"JA Lubin","year":"2018","unstructured":"Lubin JA, Zhang RR, Kuo JS (2018) Zika virus has oncolytic activity against glioblastoma stem cells. Neurosurgery 82(5):E113\u2013E1E4","journal-title":"Neurosurgery"},{"key":"1299_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.864781","volume":"9","author":"K Lundstrom","year":"2022","unstructured":"Lundstrom K (2022) Alphaviruses in cancer therapy. Front Mol Biosci 9:864781","journal-title":"Front Mol Biosci"},{"issue":"6","key":"1299_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/sj.gt.3302889","volume":"14","author":"J Lyons","year":"2007","unstructured":"Lyons J, Sheahan B, Galbraith S, Mehra R, Atkins G, Fleeton M (2007) Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice. Gene Ther 14(6):503\u2013513","journal-title":"Gene Ther"},{"issue":"7","key":"1299_CR63","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/ijc.23646","volume":"123","author":"AM M\u00e4\u00e4tt\u00e4","year":"2008","unstructured":"M\u00e4\u00e4tt\u00e4 AM, M\u00e4kinen K, Ketola A, Liimatainen T, Yongabi FN, V\u00e4h\u00e4-Koskela M et al (2008) Replication competent Semliki Forest virus prolongs survival in experimental lung cancer. Int J Cancer 123(7):1704\u20131711","journal-title":"Int J Cancer"},{"issue":"20","key":"1299_CR64","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1128\/JVI.01868-15","volume":"89","author":"M Martikainen","year":"2015","unstructured":"Martikainen M, Niittykoski M, von und zu Fraunberg M, Immonen A, Koponen S, van Geenen M et al (2015) MicroRNA-attenuated clone of virulent Semliki Forest virus overcomes antiviral type I interferon in resistant mouse CT-2A glioma. J Virol 89(20):10637\u201310647","journal-title":"J Virol"},{"issue":"11","key":"1299_CR65","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1128\/JVI.00008-08","volume":"82","author":"GR Medigeshi","year":"2008","unstructured":"Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA (2008) West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of \u03b1v\u03b23 integrin. J Virol 82(11):5212\u20135219","journal-title":"J Virol"},{"issue":"2","key":"1299_CR66","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.chom.2017.01.004","volume":"21","author":"JJ Miner","year":"2017","unstructured":"Miner JJ, Diamond MS (2017) Zika virus pathogenesis and tissue tropism. Cell Host Microbe 21(2):134\u2013142","journal-title":"Cell Host Microbe"},{"key":"1299_CR67","doi-asserted-by":"crossref","unstructured":"Morris DG, Feng X, DiFrancesco LM, Fonseca K, Forsyth PA, Paterson AH et al (2013) REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin\u00ae) in patients with advanced solid tumors. 31(3):696\u2013706","DOI":"10.1007\/s10637-012-9865-z"},{"issue":"9","key":"1299_CR68","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1172\/JCI42672","volume":"120","author":"MA Morse","year":"2010","unstructured":"Morse MA, Hobeika AC, Osada T, Berglund P, Hubby B, Negri S et al (2010) An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. J Clin Invest 120(9):3234\u20133241","journal-title":"J Clin Invest"},{"issue":"17","key":"1299_CR69","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.gt.3301263","volume":"7","author":"A Murphy","year":"2000","unstructured":"Murphy A, Morris-Downes M, Sheahan B, Atkins G (2000) Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Ther 7(17):1477\u20131482","journal-title":"Gene Ther"},{"issue":"3","key":"1299_CR70","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso D, Gubler DJ (2016) Zika virus. Clin Microbiol Rev 29(3):487\u2013524","journal-title":"Clin Microbiol Rev"},{"key":"1299_CR71","doi-asserted-by":"crossref","unstructured":"Nair S, Mazzoccoli L, Jash A, Govero J, Bais SS, Hu T et al (2021) Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade. 6(1):e144619","DOI":"10.1172\/jci.insight.144619"},{"issue":"1","key":"1299_CR72","first-page":"40","volume":"13","author":"AS Nazarenko","year":"2025","unstructured":"Nazarenko AS, Biryukova YK, Trachuk KN, Orlova EA, Vorovitch MF, Pestov NB et al (2025) Immunotherapeutic potential of the yellow fever virus vaccine strain 17D for Intratumoral therapy in a murine model of pancreatic. Cancer 13(1):40","journal-title":"Cancer"},{"issue":"12","key":"1299_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081953","volume":"8","author":"PC Neves","year":"2013","unstructured":"Neves PC, Santos JR, Tubar\u00e3o LN, Bonaldo MC, Galler R (2013) Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses. PLoS One 8(12):e81953","journal-title":"PLoS One"},{"key":"1299_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.875188","volume":"12","author":"M Nisar","year":"2022","unstructured":"Nisar M, Paracha RZ, Adil S, Qureshi SN, Janjua HA (2022) An extensive review on preclinical and clinical trials of oncolytic viruses therapy for pancreatic cancer. Front Oncol 12:875188","journal-title":"Front Oncol"},{"key":"1299_CR75","doi-asserted-by":"crossref","unstructured":"Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa C, Bershteyn M (2016) Kriegstein ARJCsc, Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. 18(5):591\u2013596","DOI":"10.1016\/j.stem.2016.03.012"},{"issue":"41","key":"1299_CR76","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1016\/j.vaccine.2014.07.051","volume":"32","author":"N Oreshkova","year":"2014","unstructured":"Oreshkova N, Cornelissen L, De Haan C, Moormann R, Kortekaas J (2014) Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen. Vaccine 32(41):5323\u20135329","journal-title":"Vaccine"},{"issue":"17","key":"1299_CR77","doi-asserted-by":"publisher","first-page":"9124","DOI":"10.1128\/JVI.01105-15","volume":"89","author":"N Oreshkova","year":"2015","unstructured":"Oreshkova N, Spel L, Vloet R, Wichgers Schreur P, Moormann R, Boes M et al (2015) Preliminary evaluation of a Bunyavirus vector for cancer immunotherapy. J Virol 89(17):9124\u20139127","journal-title":"J Virol"},{"issue":"10","key":"1299_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077461","volume":"8","author":"N Oreshkova","year":"2013","unstructured":"Oreshkova N, van Keulen L, Kant J, Moormann RJ, Kortekaas J (2013) A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. PLoS One 8(10):e77461","journal-title":"PLoS One"},{"issue":"11","key":"1299_CR79","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00262-012-1248-y","volume":"61","author":"T Osada","year":"2012","unstructured":"Osada T, Berglund P, Morse MA, Hubby B, Lewis W, Niedzwiecki D et al (2012) Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects. Cancer Immunol Immunother 61(11):1941\u20131951","journal-title":"Cancer Immunol Immunother"},{"key":"1299_CR80","doi-asserted-by":"crossref","unstructured":"Osipov ID, Vasikhovskaia VA, Zabelina DS, Kutseikin SS, Grazhdantseva AA, Kochneva GV, et al. Development of oncolytic vectors based on human adenovirus type 6 for cancer treatment 2023;15(1):182","DOI":"10.3390\/v15010182"},{"key":"1299_CR81","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2017-000530","author":"ES Paix\u00e3o","year":"2018","unstructured":"Paix\u00e3o ES, Teixeira MG, Rodrigues LC (2018) Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases. BMJ Glob Health. https:\/\/doi.org\/10.1136\/bmjgh-2017-000530","journal-title":"BMJ Glob Health"},{"issue":"4","key":"1299_CR82","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12(4):265\u2013277","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1299_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020266","volume":"8","author":"A Pattnaik","year":"2020","unstructured":"Pattnaik A, Sahoo BR, Pattnaik AK (2020) Current status of Zika virus vaccines: successes and challenges. Vaccines 8(2):266","journal-title":"Vaccines"},{"issue":"6","key":"1299_CR84","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson TC, Diamond MS (2020) The continued threat of emerging flaviviruses. Nat Microbiol 5(6):796\u2013812","journal-title":"Nat Microbiol"},{"issue":"2","key":"1299_CR85","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1517\/14712598.6.2.135","volume":"6","author":"GP Pijlman","year":"2006","unstructured":"Pijlman GP, Suhrbier A, Khromykh AA (2006) Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin Biol Ther 6(2):135\u2013145","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"1299_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biologics4010001","volume":"4","author":"S Pujhari","year":"2023","unstructured":"Pujhari S (2023) Recent advances in arboviral vaccines: emerging platforms and promising innovations. Biologics 4(1):1\u201316","journal-title":"Biologics"},{"issue":"10","key":"1299_CR87","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri2629","volume":"9","author":"B Pulendran","year":"2009","unstructured":"Pulendran B (2009) Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 9(10):741\u2013747","journal-title":"Nat Rev Immunol"},{"key":"1299_CR88","doi-asserted-by":"crossref","unstructured":"Qi Z, Zhao J, Li Y, Zhang B, Hu S, Chen Y et al (2023) Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity. 14:982180","DOI":"10.3389\/fimmu.2023.982180"},{"issue":"5","key":"1299_CR89","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1158\/2326-6066.CIR-14-0216","volume":"3","author":"JI Quetglas","year":"2015","unstructured":"Quetglas JI, Labiano S, Aznar MA, Bolanos E, Azpilikueta A, Rodriguez I et al (2015) Virotherapy with a semliki forest virus\u2013based vector encoding IL12 synergizes with PD-1\/PD-L1 blockade. Cancer Immunol Res 3(5):449\u2013454","journal-title":"Cancer Immunol Res"},{"key":"1299_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954936","volume":"13","author":"I Rastogi","year":"2022","unstructured":"Rastogi I, Jeon D, Moseman JE, Muralidhar A, Potluri HK, McNeel DG (2022) Role of B cells as antigen presenting cells. Front Immunol 13:954936","journal-title":"Front Immunol"},{"key":"1299_CR91","doi-asserted-by":"crossref","unstructured":"Reddy R, Yan SC, Segherlou ZH, Hosseini-Siyanaki M-R, Poe J, Perez-Vega C et al (2023) Oncolytic viral therapy: A review and promising future directions. 140(2):319\u2013327","DOI":"10.3171\/2023.6.JNS23243"},{"issue":"1","key":"1299_CR92","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1023\/A:1024979103780","volume":"64","author":"H Ren","year":"2003","unstructured":"Ren H, Boulikas T, S\u00f6ling A, Warnke P, Rainov N (2003) Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene\u2013a phase I\/II clinical protocol. J Neuro-Oncol 64(1):147\u2013154","journal-title":"J Neuro-Oncol"},{"issue":"50","key":"1299_CR93","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.1073\/pnas.1618029113","volume":"113","author":"H Retallack","year":"2016","unstructured":"Retallack H, Di Lullo E, Arias C, Knopp KA, Laurie MT, Sandoval-Espinosa C et al (2016) Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci USA 113(50):14408\u201314413","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1299_CR94","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2990.2010.01110.x","volume":"36","author":"F Roche","year":"2010","unstructured":"Roche F, Sheahan B, O\u2019Mara S, Atkins G (2010) Semliki forest virus-mediated gene therapy of the RG2 rat glioma. Neuropathol Appl Neurobiol 36(7):648\u2013660","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"1299_CR95","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.cgt.7700775","volume":"12","author":"MA Rochester","year":"2005","unstructured":"Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM (2005) Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther 12(1):90\u2013100","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"1299_CR96","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ymthe.2005.02.011","volume":"12","author":"JR Rodriguez-Madoz","year":"2005","unstructured":"Rodriguez-Madoz JR, Prieto J, Smerdou C (2005) Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas. Mol Ther 12(1):153\u2013163","journal-title":"Mol Ther"},{"issue":"7","key":"1299_CR97","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell SJ, Peng K-W, Bell JC (2012) Oncolytic virotherapy. Nat Biotechnol 30(7):658\u2013670","journal-title":"Nat Biotechnol"},{"key":"1299_CR98","doi-asserted-by":"publisher","first-page":"719077","DOI":"10.3389\/fimmu.2021.719077","volume":"12","author":"A Scaglione","year":"2021","unstructured":"Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG et al (2021) Combination of a Sindbis-SARS-CoV-2 spike vaccine and \u03b1OX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity. Front Immunol 12:719077","journal-title":"Front Immunol"},{"issue":"1","key":"1299_CR99","volume":"12","author":"S Shah","year":"2023","unstructured":"Shah S (2023) Novel therapies in glioblastoma treatment: review of glioblastoma; current treatment options; and novel oncolytic viral therapies. Med Sci 12(1):1","journal-title":"Med Sci"},{"issue":"3","key":"1299_CR100","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley JL, De Jong YP, Terhorst C, Herzog RW (2020) Immune responses to viral gene therapy vectors. Mol Ther 28(3):709\u2013722","journal-title":"Mol Ther"},{"issue":"6","key":"1299_CR101","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1128\/JVI.78.6.2701-2710.2004","volume":"78","author":"S Shresta","year":"2004","unstructured":"Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E (2004) Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T-and B-cell-dependent immunity are less critical. J Virol 78(6):2701\u20132710","journal-title":"J Virol"},{"issue":"3","key":"1299_CR102","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1172\/JCI84417","volume":"127","author":"LA Silva","year":"2017","unstructured":"Silva LA, Dermody TS (2017) Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest 127(3):737\u2013749","journal-title":"J Clin Invest"},{"issue":"6","key":"1299_CR103","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.vaccine.2012.11.096","volume":"31","author":"SF Slovin","year":"2013","unstructured":"Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP et al (2013) A phase i dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine 31(6):943\u2013949","journal-title":"Vaccine"},{"key":"1299_CR104","doi-asserted-by":"crossref","unstructured":"Suthar MS, Diamond MS, Gale M Jr (2013) West Nile virus infection and immunity. Nat Rev Microbiol 11(2):115\u2013128","DOI":"10.1038\/nrmicro2950"},{"issue":"6","key":"1299_CR105","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805\u2013820","journal-title":"Cell"},{"key":"1299_CR106","doi-asserted-by":"crossref","unstructured":"Tang C, Li L, Mo T, Na J, Qian Z, Fan D et al (2022) Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical. 24(9):1682\u20131701","DOI":"10.1007\/s12094-022-02830-x"},{"issue":"6","key":"1299_CR107","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-09-2408","volume":"70","author":"CM Thirukkumaran","year":"2010","unstructured":"Thirukkumaran CM, Nodwell MJ, Hirasawa K, Shi Z-Q, Diaz R, Luider J et al (2010) Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res 70(6):2435\u20132444","journal-title":"Cancer Res"},{"key":"1299_CR108","doi-asserted-by":"crossref","unstructured":"Tovar C, Graves B, Packman K, Filipovic Z, Xia BHM, Tardell C et al (2013) MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models. 73(8):2587\u20132597","DOI":"10.1158\/0008-5472.CAN-12-2807"},{"issue":"18","key":"1299_CR109","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.1158\/0008-5472.CAN-04-1924","volume":"64","author":"J-C Tseng","year":"2004","unstructured":"Tseng J-C, Hurtado A, Yee H, Levin B, Boivin C, Benet M et al (2004a) Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 64(18):6684\u20136692","journal-title":"Cancer Res"},{"issue":"1","key":"1299_CR110","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nbt917","volume":"22","author":"J-C Tseng","year":"2004","unstructured":"Tseng J-C, Levin B, Hurtado A, Yee H, de Castro IP, Jimenez M et al (2004b) Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22(1):70\u201377","journal-title":"Nat Biotechnol"},{"issue":"12","key":"1299_CR111","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1158\/1078-0432.CCR-04-2610","volume":"11","author":"Y Unno","year":"2005","unstructured":"Unno Y, Shino Y, Kondo F, Igarashi N, Wang G, Shimura R et al (2005) Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain. Clin Cancer Res 11(12):4553\u20134560","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1299_CR112","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1487913","volume":"7","author":"S van de Wall","year":"2018","unstructured":"van de Wall S, Ljungberg K, Ip PP, Boerma A, Knudsen ML, Nijman HW et al (2018) Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology 7(10):e1487913","journal-title":"Oncoimmunology"},{"issue":"8","key":"1299_CR113","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/cgt.2012.37","volume":"19","author":"J Vasilevska","year":"2012","unstructured":"Vasilevska J, Skrastina D, Spunde K, Garoff H, Kozlovska T, Zajakina A (2012) Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon. Cancer Gene Ther 19(8):579\u2013587","journal-title":"Cancer Gene Ther"},{"issue":"21","key":"1299_CR114","first-page":"7861","volume":"61","author":"MP Velders","year":"2001","unstructured":"Velders MP, McElhiney S, Cassetti MC, Eiben GL, Higgins T, Kovacs GR et al (2001) Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA. Cancer Res 61(21):7861\u20137867","journal-title":"Cancer Res"},{"issue":"6013","key":"1299_CR115","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL et al (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44\u201349","journal-title":"Science"},{"issue":"2","key":"1299_CR116","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/ijms25021180","volume":"25","author":"SR Volovat","year":"2024","unstructured":"Volovat SR, Scripcariu DV, Vasilache IA, Stolniceanu CR, Volovat C, Augustin IG et al (2024) Oncolytic virotherapy: a new paradigm in cancer immunotherapy. Int J Mol Sci 25(2):1180","journal-title":"Int J Mol Sci"},{"issue":"01","key":"1299_CR117","volume":"2021","author":"S Wang","year":"2021","unstructured":"Wang S, Guo H, Zhu-Salzman K, Ge F, Sun Y (2021) PEBP regulates balance between apoptosis and autophagy, enabling coexistence of arbovirus and insect vector. bioRxiv 2021(01):19.427364","journal-title":"bioRxiv"},{"issue":"9","key":"1299_CR118","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3390\/v5092298","volume":"5","author":"T Wang","year":"2013","unstructured":"Wang T, Welte TJV (2013) Role of natural killer and Gamma-delta T cells in West Nile virus infection. Viruses 5(9):2298\u20132310","journal-title":"Viruses"},{"issue":"5","key":"1299_CR119","doi-asserted-by":"publisher","first-page":"R580","DOI":"10.1186\/bcr1199","volume":"7","author":"X Wang","year":"2005","unstructured":"Wang X, Wang J-P, Rao X-M, Price JE, Zhou HS, Lachman LB (2005) Prime\u2013boost vaccination with plasmid and adenovirus gene vaccines control HER2\/neu+ metastatic breast cancer in mice. Breast Cancer Res 7(5):R580","journal-title":"Breast Cancer Res"},{"issue":"9","key":"1299_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/v15091801","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Shao W (2023) Innate immune response to viral vectors in gene therapy. Viruses 15(9):1801","journal-title":"Viruses"},{"issue":"2","key":"1299_CR121","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","volume":"85","author":"SC Weaver","year":"2010","unstructured":"Weaver SC, Reisen WK (2010) Present and future arboviral threats. Antivir Res 85(2):328\u2013345","journal-title":"Antivir Res"},{"issue":"12","key":"1299_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050221","volume":"7","author":"B Wolf","year":"2012","unstructured":"Wolf B, Schwarzer A, Cote AL, Hampton TH, Schwaab T, Huarte E et al (2012) Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-\u03b1 and dendritic cell vaccine. PLoS One 7(12):e50221","journal-title":"PLoS One"},{"issue":"5","key":"1299_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036435","volume":"7","author":"KL Wong","year":"2012","unstructured":"Wong KL, Chen W, Balakrishnan T, Toh YX, Fink K, Wong S-C (2012) Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One 7(5):e36435","journal-title":"PLoS One"},{"issue":"4895","key":"1299_CR124","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1126\/science.2922607","volume":"243","author":"C Xiong","year":"1989","unstructured":"Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV (1989) Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243(4895):1188\u20131191","journal-title":"Science"},{"issue":"4","key":"1299_CR125","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3171\/jns.2003.99.4.0746","volume":"99","author":"R Yamanaka","year":"2003","unstructured":"Yamanaka R, Tsuchiya N, Yajima N, Honma J, Hasegawa H, Tanaka R et al (2003) Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12. J Neurosurg 99(4):746\u2013753","journal-title":"J Neurosurg"},{"issue":"5","key":"1299_CR126","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/dna.2005.24.317","volume":"24","author":"R Yamanaka","year":"2005","unstructured":"Yamanaka R, Xanthopoulos KG (2005) Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18. DNA Cell Biol 24(5):317\u2013324","journal-title":"DNA Cell Biol"},{"issue":"10","key":"1299_CR127","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/sj.cgt.7700367","volume":"8","author":"R Yamanaka","year":"2001","unstructured":"Yamanaka R, Zullo SA, Ramsey J, Onodera M, Tanaka R, Blaese M et al (2001) Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus. Cancer Gene Ther 8(10):796\u2013802","journal-title":"Cancer Gene Ther"},{"key":"1299_CR128","doi-asserted-by":"crossref","unstructured":"Yang MR, Lee SR, Oh W, Lee EW, Yeh JY, Nah JJ et al (2008) West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. 10(1):165\u2013176","DOI":"10.1111\/j.1462-5822.2007.01027.x"},{"issue":"2","key":"1299_CR129","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbrc.2015.08.003","volume":"465","author":"X Yin","year":"2015","unstructured":"Yin X, Wang W, Zhu X, Wang Y, Wu S, Wang Z et al (2015) Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis. Biochem Biophys Res Commun 465(2):239\u2013244","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"1299_CR130","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","volume":"28","author":"YJV Yu","year":"2010","unstructured":"Yu YJV (2010) Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14\u201314-2 and their stabilities. Vaccine 28(21):3635\u20133641","journal-title":"Vaccine"},{"key":"1299_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.721830","volume":"12","author":"J Zeng","year":"2021","unstructured":"Zeng J, Li X, Sander M, Zhang H, Yan G, Lin Y (2021) Oncolytic viro-immunotherapy: an emerging option in the treatment of gliomas. Front Immunol 12:721830","journal-title":"Front Immunol"},{"issue":"29","key":"1299_CR132","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1038\/s41388-021-01869-4","volume":"40","author":"J Zhang","year":"2021","unstructured":"Zhang J, Liu Y, Tan J, Zhang Y, Wong C-W, Lin Z et al (2021a) Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with doxorubicin displays promising therapeutic efficacy in TNBC. Oncogene 40(29):4783\u20134795","journal-title":"Oncogene"},{"key":"1299_CR133","doi-asserted-by":"crossref","unstructured":"Zhang YN, Li N, Zhang QY, Liu J, Zhan SL, Gao L et al (2021b) Rational design of West Nile virus vaccine through large replacement of 3\u2032 UTR with internal poly (A). 13(9):e14108","DOI":"10.15252\/emmm.202114108"},{"issue":"10","key":"1299_CR134","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1084\/jem.20171093","volume":"214","author":"Z Zhu","year":"2017","unstructured":"Zhu Z, Gorman MJ, McKenzie LD, Chai JN, Hubert CG, Prager BC et al (2017a) Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med 214(10):2843\u20132857","journal-title":"J Exp Med"},{"key":"1299_CR135","doi-asserted-by":"crossref","unstructured":"Zhu Z, Gorman MJ, McKenzie LD, Chai JN, Hubert CG, Prager BC et al (2017b) Zika virus has oncolytic activity against glioblastoma stem cells. 214(10):2843\u20132857","DOI":"10.1084\/jem.20171093"},{"key":"1299_CR136","doi-asserted-by":"crossref","unstructured":"Zhu Z, Mesci P, Bernatchez JA, Gimple RC, Wang X, Schafer ST et al (2020) Zika virus targets glioblastoma stem cells through a SOX2-integrin \u03b1v\u03b25 axis. 26(2):187\u2013204.e10","DOI":"10.1016\/j.stem.2019.11.016"},{"key":"1299_CR137","doi-asserted-by":"crossref","unstructured":"Zimmerman O, Holmes AC, Kafai NM, Adams LJ, Diamond MS (2023) Entry receptors\u2014the gateway to alphavirus infection. J Clin Invest 133(2)","DOI":"10.1172\/JCI165307"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-025-01299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-025-01299-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-025-01299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:03:03Z","timestamp":1776261783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-025-01299-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":137,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s13365-025-01299-y","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}